Figure 2.
Survival curve of patients under two treatments (long-acting muscarinic antagonist (LAMA) vs. inhaled corticosteroids/long-acting beta2 agonist (ICS/LABA) until escalation to triple combination therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.